JP2018196385A5 - - Google Patents

Download PDF

Info

Publication number
JP2018196385A5
JP2018196385A5 JP2018145578A JP2018145578A JP2018196385A5 JP 2018196385 A5 JP2018196385 A5 JP 2018196385A5 JP 2018145578 A JP2018145578 A JP 2018145578A JP 2018145578 A JP2018145578 A JP 2018145578A JP 2018196385 A5 JP2018196385 A5 JP 2018196385A5
Authority
JP
Japan
Prior art keywords
birc5
normalized
ube2c
breast cancer
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018145578A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018196385A (ja
JP7042717B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018196385A publication Critical patent/JP2018196385A/ja
Publication of JP2018196385A5 publication Critical patent/JP2018196385A5/ja
Application granted granted Critical
Publication of JP7042717B2 publication Critical patent/JP7042717B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018145578A 2009-11-23 2018-08-02 癌の臨床転帰を予測する方法 Active JP7042717B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26376309P 2009-11-23 2009-11-23
US61/263,763 2009-11-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016129697A Division JP2016214245A (ja) 2009-11-23 2016-06-30 癌の臨床転帰を予測する方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020218527A Division JP2021058207A (ja) 2009-11-23 2020-12-28 癌の臨床転帰を予測する方法

Publications (3)

Publication Number Publication Date
JP2018196385A JP2018196385A (ja) 2018-12-13
JP2018196385A5 true JP2018196385A5 (enExample) 2019-02-28
JP7042717B2 JP7042717B2 (ja) 2022-03-28

Family

ID=44060376

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2012540103A Active JP5964752B2 (ja) 2009-11-23 2010-11-19 癌の臨床転帰を予測する方法
JP2016129697A Pending JP2016214245A (ja) 2009-11-23 2016-06-30 癌の臨床転帰を予測する方法
JP2018145578A Active JP7042717B2 (ja) 2009-11-23 2018-08-02 癌の臨床転帰を予測する方法
JP2020218527A Pending JP2021058207A (ja) 2009-11-23 2020-12-28 癌の臨床転帰を予測する方法
JP2022123265A Pending JP2022166064A (ja) 2009-11-23 2022-08-02 癌の臨床転帰を予測する方法
JP2022129605A Pending JP2022169647A (ja) 2009-11-23 2022-08-16 癌の臨床転帰を予測する方法
JP2023213416A Active JP7823012B2 (ja) 2009-11-23 2023-12-18 癌の臨床転帰を予測する方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2012540103A Active JP5964752B2 (ja) 2009-11-23 2010-11-19 癌の臨床転帰を予測する方法
JP2016129697A Pending JP2016214245A (ja) 2009-11-23 2016-06-30 癌の臨床転帰を予測する方法

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2020218527A Pending JP2021058207A (ja) 2009-11-23 2020-12-28 癌の臨床転帰を予測する方法
JP2022123265A Pending JP2022166064A (ja) 2009-11-23 2022-08-02 癌の臨床転帰を予測する方法
JP2022129605A Pending JP2022169647A (ja) 2009-11-23 2022-08-16 癌の臨床転帰を予測する方法
JP2023213416A Active JP7823012B2 (ja) 2009-11-23 2023-12-18 癌の臨床転帰を予測する方法

Country Status (13)

Country Link
US (4) US20110123990A1 (enExample)
EP (4) EP2504451B1 (enExample)
JP (7) JP5964752B2 (enExample)
AU (1) AU2010321829B2 (enExample)
CA (2) CA3043089A1 (enExample)
DK (1) DK2504451T3 (enExample)
ES (1) ES2735993T3 (enExample)
HU (1) HUE044374T2 (enExample)
IL (5) IL219051A (enExample)
MX (3) MX337650B (enExample)
NZ (1) NZ599194A (enExample)
PL (1) PL2504451T3 (enExample)
WO (1) WO2011063274A2 (enExample)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040231909A1 (en) 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure
ES2636470T3 (es) 2004-04-09 2017-10-05 Genomic Health, Inc. Marcadores de expresión génica para predecir la respuesta a la quimioterapia
CA2585571C (en) * 2004-11-05 2020-01-21 Genomic Health, Inc. Predicting response to chemotherapy using gene expression markers
US7888019B2 (en) 2006-03-31 2011-02-15 Genomic Health, Inc. Genes involved estrogen metabolism
AU2009262022A1 (en) * 2008-06-26 2009-12-30 Dana-Farber Cancer Institute, Inc. Signatures and determinants associated with metastasis and methods of use thereof
US20120041274A1 (en) 2010-01-07 2012-02-16 Myriad Genetics, Incorporated Cancer biomarkers
DK177532B1 (en) 2009-09-17 2013-09-08 Bio Bedst Aps Medical use of sPLA2 hydrolysable liposomes
MX337650B (es) * 2009-11-23 2016-03-14 Genomic Health Inc Metodos para predecir el desenlace clinico del cancer.
NZ600268A (en) 2010-01-11 2014-08-29 Genomic Health Inc Method to use gene expression to determine likelihood of clinical outcome of renal cancer
GB201009798D0 (en) 2010-06-11 2010-07-21 Immunovia Ab Method,array and use thereof
EP3812469A1 (en) 2010-07-07 2021-04-28 Myriad Genetics, Inc. Gene signatures for cancer prognosis
IL243203A (en) 2010-07-27 2017-04-30 Genomic Health Inc Method for using gene expression to determine prognosis of prostate cancer
US9605319B2 (en) 2010-08-30 2017-03-28 Myriad Genetics, Inc. Gene signatures for cancer diagnosis and prognosis
US8916344B2 (en) 2010-11-15 2014-12-23 Exact Sciences Corporation Methylation assay
US8361720B2 (en) 2010-11-15 2013-01-29 Exact Sciences Corporation Real time cleavage assay
CA2831074A1 (en) * 2011-03-26 2012-10-04 Oregon Health And Science University Gene expression predictors of cancer prognosis
US20140154691A1 (en) * 2011-06-22 2014-06-05 Oncocyte Corporation Methods and Compositions for the Treatment and Diagnosis of Bladder Cancer
US20140302042A1 (en) * 2011-07-01 2014-10-09 Dana-Farber Cancer Institute, Inc. Methods of predicting prognosis in cancer
EP2732423A4 (en) * 2011-07-13 2014-11-26 Multiple Myeloma Res Foundation Inc METHOD FOR DETECTING AND DISTRIBUTING DATA
CN104080924A (zh) * 2011-08-16 2014-10-01 昂科赛特公司 用于治疗和诊断乳腺癌的方法和组合物
SG10202010758SA (en) * 2011-11-08 2020-11-27 Genomic Health Inc Method of predicting breast cancer prognosis
JP5805518B2 (ja) 2011-12-21 2015-11-04 株式会社島津製作所 マルチプレックス大腸がんマーカーパネル
DK3179393T3 (da) 2012-01-31 2020-07-27 Genomic Health Inc Genexpressionsprofilalgoritme og -test til bestemmelse af prognosen for prostatakræft
GB201206323D0 (en) * 2012-04-10 2012-05-23 Immunovia Ab Methods and arrays for use in the same
US20150184247A1 (en) * 2012-04-20 2015-07-02 Memorial Sloan-Kettering Cancer Center Gene expression profiles associated with metastatic breast cancer
WO2014055398A1 (en) 2012-10-05 2014-04-10 Siemens Healthcare Diagnostics Inc. Method for detecting an increased risk or incidence of colorectal cancer
CA2891653A1 (en) 2012-11-16 2014-05-22 Myriad Genetics, Inc. Gene signatures for cancer prognosis
CA2902916C (en) 2013-03-14 2018-08-28 Mayo Foundation For Medical Education And Research Detecting neoplasm
KR101672531B1 (ko) * 2013-04-18 2016-11-17 주식회사 젠큐릭스 조기 유방암 예후 예측 진단용 유전자 마커 및 이의 용도
MX369911B (es) * 2013-05-30 2019-11-26 Genomic Health Inc Método basado en expresión génica para clasificar pacientes con cãncer de riñón de acuerdo al riesgo de recurrencia.
US10392667B2 (en) * 2013-06-07 2019-08-27 Medical Prognosis Institute A/S Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients
WO2015138769A1 (en) * 2014-03-12 2015-09-17 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for assessing patients with non-small cell lung cancer
CA2947624A1 (en) * 2014-05-13 2015-11-19 Myriad Genetics, Inc. Gene signatures for cancer prognosis
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
DK3198035T3 (da) 2014-09-26 2023-01-30 Allarity Therapeutics Europe ApS Fremgangsmåder til forudsigelse af medicinrespons
WO2016092299A1 (en) * 2014-12-09 2016-06-16 Medical Research Council Methods and kits for predicting the response to therapy of cancer
US10435755B2 (en) 2015-03-27 2019-10-08 Exact Sciences Development Company, Llc Detecting esophageal disorders
CN114574585A (zh) 2015-08-31 2022-06-03 梅约医药教育及研究基金会 检测胃肿瘤
CN108350485A (zh) 2015-10-30 2018-07-31 精密科学发展有限责任公司 血浆dna的多重扩增检测测定以及分离和检测
CA3008273A1 (en) 2015-12-18 2017-06-22 Clear Gene, Inc. Methods, compositions, kits and devices for rapid analysis of biological markers
CN109563546B (zh) 2016-05-05 2022-09-09 精密科学发展有限责任公司 通过分析甲基化dna来检测肺肿瘤
SG11201901466PA (en) * 2016-09-07 2019-03-28 Agency Science Tech & Res A method of identifying risk of cancer and therapeutic options
US9725769B1 (en) 2016-10-07 2017-08-08 Oncology Venture ApS Methods for predicting drug responsiveness in cancer patients
AU2017258901A1 (en) 2016-12-30 2018-07-19 Allarity Therapeutics Europe ApS Methods for predicting drug responsiveness in cancer patients
KR102892245B1 (ko) 2017-01-27 2025-11-27 이그젝트 싸이언스 디블롭먼트 컴패니, 엘엘씨 메틸화된 dna 분석에 의한 결장 신조직형성의 검출
WO2018212192A1 (ja) * 2017-05-18 2018-11-22 京都府公立大学法人 癌の予後及び／又は転移可能性を評価する方法及びマーカー
US12275994B2 (en) * 2017-06-22 2025-04-15 Clear Gene, Inc. Methods and compositions for the analysis of cancer biomarkers
EP3513280A4 (en) 2017-11-13 2020-07-22 The Multiple Myeloma Research Foundation, Inc. INTEGRATED, MOLECULAR, OMIC, IMMUNOTHERAPY, METABOLIC, EPIGENETIC AND CLINICAL DATABASE
US10648025B2 (en) 2017-12-13 2020-05-12 Exact Sciences Development Company, Llc Multiplex amplification detection assay II
AU2019230200A1 (en) * 2018-03-08 2020-10-29 University Of Notre Dame Du Lac Systems and methods for assessing colorectal cancer molecular subtype and risk of recurrence and for determining and administering treatment protocols based thereon
JP7199045B2 (ja) * 2018-04-13 2023-01-05 国立大学法人大阪大学 乳癌の予後に関する情報の取得方法、乳癌の予後の判定装置及びコンピュータプログラム
JP7444376B2 (ja) * 2018-09-21 2024-03-06 国立大学法人 東京大学 がんの予後判定方法
JP2019032334A (ja) * 2018-10-03 2019-02-28 イムノヴィア・アクチエボラーグ 乳癌関連の疾患状態を決定する方法およびこの方法における使用のためのアレイ
KR102216645B1 (ko) * 2018-10-29 2021-02-17 사회복지법인 삼성생명공익재단 폐암의 분자 아형 결정을 위한 바이오마커 패널 및 이의 용도
SG11202106130UA (en) * 2018-12-08 2021-07-29 Pfs Genomics Inc Transcriptomic profiling for prognosis of breast cancer
WO2020226333A1 (ko) * 2019-05-03 2020-11-12 주식회사 디시젠 암 예후 예측방법 및 이의 조성물
CN111235270B (zh) * 2019-08-29 2022-04-29 北京臻知医学科技有限责任公司 一种基于高通量测序法的肿瘤抗原表达检测引物及试剂盒
US12165747B2 (en) * 2020-01-23 2024-12-10 The Broad Institute, Inc. Molecular spatial mapping of metastatic tumor microenvironment
AU2022220330A1 (en) * 2021-02-12 2023-09-14 Mammogen, Inc. Biomarkers for the diagnosis of breast cancer
US20220285032A1 (en) * 2021-03-08 2022-09-08 Castle Biosciences, Inc. Determining Prognosis and Treatment based on Clinical-Pathologic Factors and Continuous Multigene-Expression Profile Scores
CN117116345B (zh) * 2023-07-24 2025-09-16 中国人民解放军军事科学院军事医学研究院 一种基于基因调控网络构建患者生存网络的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7171311B2 (en) * 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
EP1410011B1 (en) * 2001-06-18 2011-03-23 Rosetta Inpharmatics LLC Diagnosis and prognosis of breast cancer patients
WO2003004989A2 (en) * 2001-06-21 2003-01-16 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
ES2374311T3 (es) * 2002-03-13 2012-02-15 Genomic Health, Inc. Obtención de perfil de expresión génica en tejidos tumorales biopsiados.
US20040067234A1 (en) * 2002-07-11 2004-04-08 Paz Einat Isocitrate dehydrogenase and uses thereof
US20040231909A1 (en) * 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure
AU2004258085B2 (en) * 2003-07-10 2010-05-27 Genomic Health, Inc. Expression profile algorithm and test for cancer prognosis
JP2007527247A (ja) * 2004-03-05 2007-09-27 ロゼッタ インファーマティクス エルエルシー 臨床的基準および情報提供性遺伝子セットの組合せを使用する乳癌患者の分類
EP1797429A2 (en) * 2004-09-30 2007-06-20 Bayer HealthCare AG Methods and kits for the prediction of therapeutic success and recurrence free survival in cancer therapy
WO2006103442A2 (en) * 2005-04-01 2006-10-05 Ncc Technology Ventures Pte. Ltd. Materials and methods relating to breast cancer classification
WO2006133460A2 (en) * 2005-06-09 2006-12-14 Yale University Methods for diagnosing and treating breast cancer based on a her/er ratio
US20070099209A1 (en) * 2005-06-13 2007-05-03 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
AU2006259583A1 (en) * 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
TWI304443B (en) * 2005-12-30 2008-12-21 Nat Health Research Institutes Alpha-enolase specific antibody and method of use
US7888019B2 (en) * 2006-03-31 2011-02-15 Genomic Health, Inc. Genes involved estrogen metabolism
US20100234292A1 (en) * 2007-04-16 2010-09-16 Ipsogen Methods of assessing a propensity of clinical outcome for a female mammal suffering from breast cancer
WO2008150512A2 (en) * 2007-06-04 2008-12-11 University Of Louisville Research Foundation, Inc. Methods for identifying an increased likelihood of recurrence of breast cancer
WO2009095319A1 (en) * 2008-01-28 2009-08-06 Siemens Healthcare Diagnostics Gmbh Cancer prognosis by majority voting
WO2009132928A2 (en) * 2008-05-02 2009-11-05 Siemens Healthcare Diagnostics Gmbh Molecular markers for cancer prognosis
EP2294215B1 (en) * 2008-05-12 2013-01-16 Genomic Health, Inc. Tests to predict responsiveness of cancer patients to chemotherapy treatment options
MX337650B (es) * 2009-11-23 2016-03-14 Genomic Health Inc Metodos para predecir el desenlace clinico del cancer.

Similar Documents

Publication Publication Date Title
JP2018196385A5 (enExample)
JP2016214245A5 (enExample)
Huang et al. Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer
Smirnov et al. Global gene expression profiling of circulating tumor cells
JP2020188787A (ja) 膵臓がんの検出キット又はデバイス及び検出方法
JP2010538609A5 (enExample)
JP2016174600A5 (enExample)
CN106148529B (zh) 与胃癌相关的LncRNA标记物及其专用检测引物、检测方法、试剂盒与应用
CN105603101B (zh) 检测8个miRNA表达量的系统在制备诊断或辅助诊断肝细胞癌产品中的应用
Marín-Aguilera et al. Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer
JP2016521979A5 (enExample)
Wan et al. Diagnostic significance of circulating long noncoding RNA PCAT6 in patients with non-small cell lung cancer
JP6611411B2 (ja) 膵臓がんの検出キット及び検出方法
Zhao et al. Diagnostic value of NKG2D promoter methylation in hepatitis B virus-associated hepatocellular carcinoma
JP2021531831A5 (enExample)
Zhu et al. Long intergenic non-protein coding RNA 1006 used as a potential novel biomarker of gastric cancer
CN110760584A (zh) 前列腺癌疾病进展生物标志物及其应用
CN109477147A (zh) 用于皮肤癌分期和治疗的方法和材料
AU2017282420A1 (en) MMP1 gene transcript for use as marker for diagnosis of ovarian cancer prognosis, and test method
Lin et al. Down-regulation of tissue microRNA-126 was associated with poor prognosis in patients with cutaneous melanoma
Jani et al. Examining trends in kidney cancer mortality by gender and race in the United States: A 20-year analysis
CN107858424B (zh) miRNA-4731-3p作为原发性肺癌诊断标志物的应用
WO2020135422A1 (zh) 健康风险评估方法
RU2663078C1 (ru) Способ прогнозирования риска развития послеоперационных сердечно-сосудистых осложнений лапароскопических операций при метастатическом раке толстой кишки
KR102935486B1 (ko) 혈중 무세포 dna 기반 유방암 치료 예후예측 방법